Lexaria Bioscience (LEXX) Cash from Investing Activities (2010 - 2026)
Lexaria Bioscience (LEXX) posted Cash from Investing Activities of -$27,089 for fiscal Q3 2026 (quarter ended May 31, 2026), compared with -$19,443 a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Cash from Investing Activities (2010 - 2026) Analysis & Trends
For the trailing twelve months through May 31, 2026, Cash from Investing Activities at Lexaria Bioscience was -$243,975; for FY2025 (ended Aug 31, 2025), it came in at -$243,019.
- In prior fiscal years, Lexaria Bioscience's Cash from Investing Activities was -$188,605 in FY2024, -$169,610 in FY2023, -$180,640 in FY2022 and $193,880 in FY2021.
- Quarterly Cash from Investing Activities has run from a low of -$157,878 in fiscal Q4 2025 to a high of -$2.00 in fiscal Q4 2021 over five years.
- According to Business Quant data, Cash from Investing Activities for the three prior fiscal quarters was -$53,909 (Q2 2026), -$5,099 (Q1 2026) and -$157,878 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - | -27,089.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -27,089.00 |
| Feb 28, 2026 | -53,909.00 |
| Nov 30, 2025 | -5,099.00 |
| Aug 31, 2025 | -157,878.00 |
| May 31, 2025 | -19,443.00 |
| Feb 28, 2025 | -27,894.00 |
| Nov 30, 2024 | -37,804.00 |
| Aug 31, 2024 | -69,587.00 |
| May 31, 2024 | -22,002.00 |
| Feb 29, 2024 | -56,990.00 |
| Nov 30, 2023 | -40,026.00 |
| Aug 31, 2023 | -68,437.00 |
| May 31, 2023 | -33,647.00 |
| Feb 28, 2023 | -32,684.00 |
| Nov 30, 2022 | -34,842.00 |
| Aug 31, 2022 | -50,045.00 |
| May 31, 2022 | -37,957.00 |
| Feb 28, 2022 | -34,423.00 |
| Nov 30, 2021 | -58,215.00 |
| Aug 31, 2021 | -2.00 |
API Access
Lexaria Bioscience Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();